Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study will assess the nasal eradication of SA in healthy subjects following treatment
with mupirocin 2% (Bactroban 2% Nasal Ointment) twice daily for 5 days, by means of a broth
enriched culture microbial assay. The sensitivities of broth enrichment and plating assay
methods will be compared. The safety and tolerability of Bactroban 2% Nasal Ointment will
also be assessed.